Global mRNA Vaccines and Therapeutics Competitive Landscape Professional Research Report 2025
Description
Global mRNA Vaccines and Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
mRNA (messenger RNA) vaccines and therapeutics are a groundbreaking class of medical treatments and preventive measures that use synthetic strands of messenger RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such as COVID-19. They work by introducing a small piece of synthetic mRNA that codes for a harmless part of the target pathogen, prompting the immune system to produce an immune response. Similarly, in therapeutics, mRNA can be used to instruct cells to create therapeutic proteins, offering potential treatments for various medical conditions, including genetic diseases and cancer. mRNA technology has shown great promise due to its flexibility, rapid development potential, and adaptability in responding to emerging health challenges, marking a significant advancement in the fields of vaccination and medical treatment.
According to DIResearch's in-depth investigation and research, the global mRNA Vaccines and Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of mRNA Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of mRNA Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global mRNA Vaccines and Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the mRNA Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of mRNA Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Vaccines and Therapeutics Product Application Include:
Disease Prevention Market
Tumor Immunity Market
Protein Replacement Therapy Market
Regenerative Therapy Market
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global mRNA Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Vaccines and Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global mRNA Vaccines and Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global mRNA Vaccines and Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa mRNA Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global mRNA Vaccines and Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 mRNA Vaccines and Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 mRNA Vaccines and Therapeutics Product by Type
- 1.2.1 Vaccines
- 1.2.2 Therapeutics
- 1.3 mRNA Vaccines and Therapeutics Product by Application
- 1.3.1 Disease Prevention Market
- 1.3.2 Tumor Immunity Market
- 1.3.3 Protein Replacement Therapy Market
- 1.3.4 Regenerative Therapy Market
- 1.4 Global mRNA Vaccines and Therapeutics Market Size Analysis (2020-2032)
- 1.5 mRNA Vaccines and Therapeutics Market Development Status and Trends
- 1.5.1 mRNA Vaccines and Therapeutics Industry Development Status Analysis
- 1.5.2 mRNA Vaccines and Therapeutics Industry Development Trends Analysis
- 2 mRNA Vaccines and Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 mRNA Vaccines and Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global mRNA Vaccines and Therapeutics Market Analysis by Regions
- 4.1 mRNA Vaccines and Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global mRNA Vaccines and Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global mRNA Vaccines and Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global mRNA Vaccines and Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global mRNA Vaccines and Therapeutics Market Size by Type and Application
- 5.1 Global mRNA Vaccines and Therapeutics Market Size by Type (2020-2032)
- 5.2 Global mRNA Vaccines and Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America mRNA Vaccines and Therapeutics Market Size by Type
- 6.4 North America mRNA Vaccines and Therapeutics Market Size by Application
- 6.5 North America mRNA Vaccines and Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe mRNA Vaccines and Therapeutics Market Size by Type
- 7.4 Europe mRNA Vaccines and Therapeutics Market Size by Application
- 7.5 Europe mRNA Vaccines and Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China mRNA Vaccines and Therapeutics Market Size by Type
- 8.4 China mRNA Vaccines and Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Type
- 9.4 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Application
- 9.5 APAC (excl. China) mRNA Vaccines and Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America mRNA Vaccines and Therapeutics Market Size by Type
- 10.4 Latin America mRNA Vaccines and Therapeutics Market Size by Application
- 10.5 Latin America mRNA Vaccines and Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa mRNA Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Type
- 11.4 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Application
- 11.5 Middle East & Africa mRNA Vaccines and Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global mRNA Vaccines and Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 mRNA Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 mRNA Vaccines and Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Moderna Therapeutics
- 13.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Moderna Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 13.1.3 Moderna Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CureVac
- 13.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CureVac mRNA Vaccines and Therapeutics Product Portfolio
- 13.2.3 CureVac mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Translate Bio
- 13.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Translate Bio mRNA Vaccines and Therapeutics Product Portfolio
- 13.3.3 Translate Bio mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 BioNTech
- 13.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 BioNTech mRNA Vaccines and Therapeutics Product Portfolio
- 13.4.3 BioNTech mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Sangamo Therapeutics
- 13.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 13.5.3 Sangamo Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Argos Therapeutics
- 13.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Argos Therapeutics mRNA Vaccines and Therapeutics Product Portfolio
- 13.6.3 Argos Therapeutics mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 In-Cell-Art
- 13.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 In-Cell-Art mRNA Vaccines and Therapeutics Product Portfolio
- 13.7.3 In-Cell-Art mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 eTheRNA
- 13.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 eTheRNA mRNA Vaccines and Therapeutics Product Portfolio
- 13.8.3 eTheRNA mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Ethris
- 13.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Ethris mRNA Vaccines and Therapeutics Product Portfolio
- 13.9.3 Ethris mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Tiba Biotechnology
- 13.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Tiba Biotechnology mRNA Vaccines and Therapeutics Product Portfolio
- 13.10.3 Tiba Biotechnology mRNA Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 mRNA Vaccines and Therapeutics Industry Chain Analysis
- 14.2 mRNA Vaccines and Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 mRNA Vaccines and Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 mRNA Vaccines and Therapeutics Typical Downstream Customers
- 14.4 mRNA Vaccines and Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
